EFFECTS OF THE NMDA-ANTAGONIST, MK-801, ON STRESS-INDUCED ALTERATIONS OF DOPAMINE DEPENDENT BEHAVIOR

被引:8
|
作者
MELE, A [1 ]
CABIB, S [1 ]
OLIVERIO, A [1 ]
机构
[1] CNR,IST PSICOBIOL & PSICOFARMACOL,I-00185 ROME,ITALY
关键词
DOPAMINE; GLUTAMATE; CHRONIC STRESS; APOMORPHINE; MK801; CLIMBING BEHAVIOR; MOUSE;
D O I
10.1007/BF02246106
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effects of pretreatment with the noncompetitive NMDA antagonist (+)MK-801 on the behavioral alterations induced by repeated restraint stress were investigated. Repeatedly stressed (restraint stress 2 h a day x 10 days) mice showed enhanced sensitivity to the inhibitory effects of a low dose of direct dopamine agonist, apomorphine (0.25 mg/kg), on climbing behavior. On the other hand, no changes were observed for the stimulatory effect of the high dose of apomorphine (3 mg/kg) on this behavioral response. Mice pretreated with MK-801 (0.15 mg/kg) before the stressful experience did not show altered response to the low dose of apomorphine (0.25 mg/kg). Finally, ten daily injections with 0.15 mg/kg MK-801 did not affect the behavioral response to the low dose of apomorphine, but enhanced the stimulatory effect of the high dose of the dopaminergic agonist on climbing behavior. Therefore, it is possible that the protective action of MK-801 against stress-induced behavioral alteration is due to changes in sensitivity of postsynaptic receptors.
引用
收藏
页码:313 / 317
页数:5
相关论文
共 50 条
  • [1] SEX-DIFFERENCES IN THE INHIBITORY EFFECTS OF THE NMDA ANTAGONIST, MK-801, ON MORPHINE AND STRESS-INDUCED ANALGESIA
    LIPA, SM
    KAVALIERS, M
    [J]. BRAIN RESEARCH BULLETIN, 1990, 24 (04) : 627 - 630
  • [2] NMDA RECEPTOR ANTAGONIST MK-801 BLOCKS NONOPIOID STRESS-INDUCED ANALGESIA IN THE FORMALIN TEST
    VACCARINO, AL
    MAREK, P
    STERNBERG, W
    LIEBESKIND, JC
    [J]. PAIN, 1992, 50 (01) : 119 - 123
  • [3] Effects of NMDA antagonist, MK-801 on spatial exploratory behavior in the rat
    Sekiguchi, R
    [J]. JAPANESE JOURNAL OF PSYCHOLOGY, 1997, 68 (02): : 88 - 94
  • [4] PHARMACOLOGY AND NEUROPROTECTIVE EFFECTS OF THE NMDA ANTAGONIST MK-801
    IVERSEN, LL
    WOODRUFF, GN
    KEMP, JA
    FOSTER, A
    GILL, R
    WONG, E
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1987, 28 (01) : 127 - 127
  • [5] Profiling of gene expression in rat brain after cocaine and NMDA-antagonist MK-801 treatments
    Storvik, M
    Lakso, M
    Wong, G
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 19 : S25 - S25
  • [6] Reconsolidation-blockade of an amphetamine-induced conditioned place-preference by the noncompetitive NMDA-antagonist MK-801
    Sadler, R.
    Herzig, V.
    Schmidt, Wj.
    [J]. BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S84 - S84
  • [7] EFFECT OF THE NMDA-ANTAGONIST, MK-801, ON BENZODIAZEPINE-OPIOID INTERACTIONS AT THE SPINAL AND SUPRASPINAL LEVEL IN RATS
    LUGER, TJ
    LORENZ, IH
    GRABNERWEISS, C
    HAYASHI, T
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (05) : 1097 - 1103
  • [8] Modeling the effects of the NMDA receptor antagonist MK-801 on timing in rats
    McAuley, J. Devin
    Miller, Jonathan P.
    Pang, Kevin C. H.
    [J]. BEHAVIORAL NEUROSCIENCE, 2006, 120 (05) : 1163 - 1168
  • [9] SYSTEMIC ADMINISTRATION OF THE NMDA RECEPTOR ANTAGONIST MK-801 POTENTIATES CIRCLING INDUCED BY INTRASTRIATAL MICROINJECTION OF DOPAMINE
    STPIERRE, JA
    BEDARD, PJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 272 (2-3) : 123 - 129
  • [10] Stress-induced glutamate efflux blocked by (+)MK-801
    Steciuk, M
    Kram, M
    Kramer, GL
    Petty, F
    [J]. BIOLOGICAL PSYCHIATRY, 1999, 45 (08) : 87S - 88S